Obesity Clinical Trial
Official title:
North Carolina WISEWOMAN Study - Weight-Wise Program
The purpose of this study is to test the effectiveness of a weight loss and weight loss maintenance intervention among low income women, conducted in a community health center setting.
In the North Carolina WISEWOMAN Project, nearly three-fourths of all participants are either
overweight or obese. Through control of weight, cardiovascular disease risk factors such as
hypertension, dyslipidemia, and type 2 diabetes can be reduced along with their associated
mortality. While there is some evidence of successful weight loss programs in the scientific
literature, there are limited data on strategies to improve the weight loss outcomes of
African Americans and other lower income populations and how to maintain weight loss over
the long term with strategies that are feasible for health care agencies that service
primarily lower income populations. We have designed a program to test intervention
strategies to improve the weight loss outcomes of the WISEWOMAN population. Specifically,
the purpose of the North Carolina WISEWOMAN Weight Control Pilot Study, "Weight-Wise"
Program, is to test the effectiveness of a weight loss and weight loss maintenance
intervention among WISEWOMAN participants, conducted in a community health center in
Wilmington, NC. The Weight-Wise Program was launched in February 2005 and will continue
through the Spring of 2007.
The study design and intervention are briefly described. Each WISEWOMAN participant was
invited to a screening visit at the health center. During an interview with a research
assistant, the participant answered a series of questions about her health history, diet,
physical activity, and weight management behaviors, and psycho-social attributes. She also
had her height, weight, blood pressure, and body composition measured. A non-fasting venous
blood specimen was taken to measure her blood lipids (total and HDL-cholesterol) and random
blood glucose. Additional baseline measures for psycho-social variables were obtained via
telephone administration. Participants who completed the screening visit, phone interview,
and met all eligibility requirements were randomized to two treatment groups: the Special
Intervention (SI) group, and the Delayed Intervention (DI) group. Participants assigned to
the SI group began the 4-month weight loss phase of the study in April 2005, while DI
participants will wait until the end of this first program offering to begin the weight loss
program. [DI participants are considered the 'control' group.]
The intervention program, called "Weight-Wise", consists of a four-month weight loss
intervention phase, and a one-year maintenance phase. During the weight loss intervention,
participants are offered 16 weekly group education sessions taught by a health counselor.
The study goal for weight loss during this period is 10 or more pounds. Each session lasts
about 120 minutes and includes the following elements: participant weigh-in, group sharing
and problem-solving, discussion of a weight control topic (nutrition, physical activity, or
behavior change), moderate physical activity and/or taste-testing. Study participants who
complete the weight loss program and lose 8 or more pounds will be eligible to continue in
the maintenance phase of the intervention. During the 1-year maintenance phase (which will
start at the end of the weight loss phase for both SI and DI), participants in the SI group
will receive 1 individual face-to-face contact with the health counselor, 8 monthly phone
contacts, and 3 group sessions. The DI group will receive 1 individual face-to-face contact
and 11 phone contacts from the health counselor during their maintenance intervention. After
the weight loss phase and after 6 and 12 months of the maintenance intervention, both SI and
DI participants will return to the clinic for follow-up data collection.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |